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Anti-cancer action of metal complexes: electron
transfer and oxidative stress?
P. Kovacic 1, W.J. Popp 1, J.R. Ames 1 & M.D. Ryan 2
'Department of Chemistry, University of Wisconsin-Milwaukee, Milwaukee. Wisconsin 53201.
and 2Department of Chemistry. Marquette University. Milwaukee, Wisconsin 53233, USA

Summary: Evidence is presented in support of an electron transfer mechanism for various metal
complexes possessing anti-neoplastic properties. Cyclic voltammetry was performed on several
metallocenes, his(acetato)bis(imidazole)Cu(II), and coordination compounds (Cu or Fe) of the antitumor agents, bipyridine, phenanthrolinc, hydroxyurea, diethyldithiocarbamatc, and a,a'-bis(Shydroxyquinolin-7-yl)-4-methoxytoluene. The favorable reduction potentials ranged from + 0.5 to
-0.5 V. Electrochemical behavior is correlated in some cases with structure and physiological
activity. Relevant literature data are discussed.

Although the mechanisms by which xcnobiotics
operate are becoming better understood, many
questions still remain. Several decades ago, the
hypothesis was advanced that oxygen radical
entities play an important role in the cancer
process (Brues & Guzman Barron, 1951; Harman, 1956, 1962; Holman, 1956; Kovacic, 1959,
1960). These moieties can attack cellular constituents, e.g. DNA, resulting in transformations
that may give rise to the oncogenic state. At
about the same time, oxy radicals were suggested to play a major role in anti-cancer action
(Holman, 1956; Kovacic, 1959). These concepts
have received recent support (Kovacic et a/.,
1986; Oberley & Buettner, 1979; Lawn, 1985).
Many carcinogens display anti-cancer action
and vice versa (Kovacic et at.• 1986). Reactive
oxygen species seem to be implicated in both
cases. Indeed, certain tumor cells are more sensitive than normal ones to elevated concentrations
of oxy radicals (Kovacic, 1959; Oberley &
Buettner, 1979).
The basic scheme entails abstraction of electrons from cellular material by a catalytic electron transfer (ET) agent bound to the active site.
The oxy radicals produced by conveyance of
electrons to oxygen then attack vital cellular
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components. In some cases, ET may result in
interference with normal electronic processes.
The principal categories of ET agents arc metal
complexes, quinoncs, ArN0 2 • iminium ions,
aromatic azo compounds, and llavins. It has
been shown that many anti-cancer agents fit into
these classifications (Kovacic eta/., 1986; Kava·
cic et at.• 1987a; Kovacic et a/., 1988a; Kovacic
et a/., 1988b; Kovacic et a/., 1988t). Metal
species produce a number of responses in biological systems relevant to the present discussion, namely oxygen radical generation (Ames,
1983; Kovacic eta/., 1986; Czapski & Goldstein,
1987), DNA strand cleavage (Furst & Radding,
1984; Czapski & Goldstein, 1987), and DNA
complex formation (Furst & Radding, 1984;
Saenger, 1984). Moreover, ET has been suggested to play an important mechanistic role
(Lumme & Elo, 1985; Czapski & Goldstein,
1987).
The objective of this work was to ascertain the
electrochemical characteristics or various drugs
belonging to the metal category of anti-cancer
agents. Cobaltocenium hexalluorophosphate
(Cp 2 CoPF 6), ruthcnocenc (Cp,Ru), nickelocene
(Cp 2 Ni), titanocene dichloride (Cp 2TiC1 2 ), and
his(acetato)bis- (imidazole)copper (ll) [Cu(OAc)2
(Hlm) 2] were investigated. The anti-tumor
agents, bipyridine (bipy), o-phenanthroline
(phen), hydroxyurea (HU). diethyldithiocarba~:C
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mate (DOC), and a, a' -bis(8-hydroxyquinolin7-yl)-4-methoxytoluene were examined in the
form of their metal complexes (Fe or Cu).
Materials and methods

The metal complexes, Cu(phen) 2(N0 3) 2 (Faye,
1966), and Cu(bipy) 2(N0 3) 2 (Hathaway et a/.,
1969) were prepared by literature methods; elemental analyses were satisfactory. The 8-hydroxyquinoline derivative, I was synthesized by
the method of Yamato eta/. (1987) except that
solvent was omitted. The n.m.r. spectrum
matched that reported; elemental analysis was
satisfactory; mass spectrum, (Cl), 409
(M+ + 1)(100%). However, the m.p. (148150oC) disagreed with the reported value of 200203oC; this may be due to the presence of
structural isomers.

For complexes prepared in solution (Cu
(bipy),(NO,),, Cu(HU),(N0 3) 2, Fe(HU)Cl 3,
FeCl,·DDC(l:l), Cu(N0 3) 2·DDC(l:l), FeCI 3·1
(2:1); and [Cu(0Ac),(Hlm) 2]), the precursors
were allowed to react for 30 min before electrochemical measurements were performed. The
Fe(HU)Cl 3 solutions were generated in dimethylformamide due to instability of the complex
under aqueous conditions (Harman eta/., 1970).
An aqueous ethanolic solution of bis(acetato)
bis(imidazole)copper(II) reduced with an £ 1 of
0.36 V. Copper(II) acetate reduced with adsorption at 0.17V.
Metallocenes and ligands were obtained from
Aldrich Chemical Co.; other reagents and electrochemical procedures have been previously
reported (Ames et a/., 1987a; Crawford et a/.,
1986; Kovacic et a/., 1987b). A platinum flag
(7 x 9 mm) was used as the working electrode.
All values reported are versus NHE (SCE values
adjusted by 0.24 V) at a scan rate of 100 mY /s.
Results and discussion

Metallocenes

Metallocenes and metallocene dihalides exhibit
anti-tumor activity (Kopf-Maier et a/., 1980;
Kopf-Maier et a/., 198la and b; Kopf-Maier,
1985; Kopf-Maier et a/., 1985), the degree of
which is highly dependent on the transition
metal (Kopf-Maier et at., 198la). The most

effective compounds, which have received the
most attention, are the dihalides whose activities

are comparable to that of cis-platin (KopfMaier et a/., 198la). The hypothesis has been
advanced that metallocenes exert their action by
a mechanism similar to the cis-platin case
(Kopf-Maier and Kopf, 1980) in which the
compound in the blood exists as a neutral molecule that is able to penetrate the cell membrane
by passive diffusion (Dombrowski et a/., 1986).
Chloride ion concentration inside the cell is very
low compared to that in blood. Therefore, as the
agent enters the cell it undergoes aqueous dissociation of the halide to produce a positively
charged species that can react with nucleophilic
sites located in the cell.
The transition metal is fundamental to the
activity of these compounds, due in part to
complexation with DNA. It is essential that the
coordination geometry or 'bite' of the agent fits
the site of attack on the helix (Kopf-Maier eta/.,
198lb). Guanosine residues may be the binding
entities, since they serve in this capacity for
related species (Tamura eta/., 1987). The resulting coordination compound may subsequently
participate in ET. Hence, it is reasonable that
the electrochemical characteristics of the metallocenes may also play a major role.
Table I lists the reduction potentials of
various metallocenes. All of the active compounds reduced in the favorable range of + 0.40
to -0.44 V, based on the present work and
literature data. The most potent anti-tumor
agents are Cp2TiCI 2 , Cp 2TiBr 2, Cp2VCI 2 and
Cp,NbBr, (Kopf-Maier and Kopf, 1980; KopfMaier et ·a/., 1981 a and b). A lower level of
activity is exhibited by Cp,Fe+ (Kopf-Maier,
1985). Cp 2ZrBr3, which has no anti-tumor
action (Kopf-Maier et a/., 1980), does not reduce in an aqueous medium. No information
was found concerning the activities of
Cp2CoPF6, Cp2Ni, and Cp,Ru. Cp 2TaBr 3, which
is not chemically reducible, shows sporadic antitumor effects (Kopf-Maier et a/., 198lb).
Although there is some correlation between
reduction potential and activity, exceptions are
seen. It is reasonable to expect important involvement of other factors also.
Bis ( acetato) bis( imidazole) copper( II)
Recently,

bis(acetato)bis(imidazole)copper(II),
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Table I

Reduction values for metallocenes and metallocene halidesa

Compound

Cp,TiCI,
Cp,TiBr,
Cp,VCI,
Cp,NbBr,

Reduction values
80% EtOH (E,)
H,O (E 1)

-0.44
-0.29"
-0.17"
- 0.29"',- 0.56"·'
NR"
NR"

Cp2TaBr 3
Cp2ZrBr 3

Cp,CoPF,
Cp,FeCp2Ni
Cp,Ru

NR
+0.40'
+0.01
NR

'Scouting experiments in DMF gave appreciably more negative values for
Cp,TiCI 2, but more positive for Cp 2Ni
~wilkinson and Birmingham, 1954
'In NaCI0 4 solution
dJn HC10 4 solution
<Reversible value from Cp2Fe oxidation (Gagne eta!., 1980)

[Cu(OAc),(Hlm),)], was found to possess strong
anti-tumor activity (Tamura et al., I 987). From
cyclic voltammetry, the reduction potential of
the complex in aqueous ethanol was 0.36 V with
a difference in cathodic and anodic peak potentials of 160 mV; the reaction was 100% reversible. Alone, Cu(0Ac) 2 reduced at E, ~ 0.17 V
with adsorption. It is evident that imidazole
favorably influences conversion of Cu(II) to
Cu(l). Prior investigators found a value of
0.32 V as the E*r for an aqueous copper(II)
imidazole complex (James & Williams, 1961).
Studies with the restriction enzyme Ban I
indicate that [Cu(OAc),(Him),] binds to the
guanosine residues of DNA (Tamura et al.,
1987). The resulting metal purine coordination
compound may be capable of redox chemistry
leading to generation of oxy radicals in a sitespecific manner, analogous to related xenobiotics (Bachur et al., I 982; Barton, 1986). [Cu(OAc)2(Hlm)2] is comparable in cytoxicity to cisplatin and superior to mitomycin C (Tamura et
a/., 1987), which are believed to participate in
ET reactions (Kovacic et al., I 986). This complex has been examined as a model for the redox
couple in copper proteins (Henriksson et a!.,
1976; Henriksson, 1977).

Metal chelators
Bipyridine and phenanthroline The chelating
agents 2,2'-bipyridine, (bipy) and o-phenanthroline, (phen), as well as derivatives, are antineoplastic (Letier et al., I 953; Dwyer et a/., 1965;
Mayhew et al., 1965; Shulman et al., 1977). It is
likely that these agents exert their activity via
complexation with metals such as copper or
iron. Although coordination with iron is more
likely due to the larger in vivo pool, o-phenanthroline has been observed to complex with Cu
in several tissues (Gutteridge, 1984). Our discussion will mainly involve Cu, the metal most
widely studied.
The electrochemical behavior of complexes
of bipy and phen were determined.
Cu(phen) 2(N0 3) 2 reduced in a quasi-reversible
manner with £ 1 of 0.34 V and 6£ of 105 mV
(Table II). The reaction was diffusio~ controlled
with an i,)ili' value slightly larger than one (I. I).
The ratio ot the current function (CF) (benzil as
reference) (Ryan & Evans, 1976) was 0.59, indicating the transfer of one electron. The small
value of the ratio is due to the lower diffusion
coefficient expected for the cation. The complex
was not studied in aqueous ethanol due to
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Table II

Cyclic voltammetry of metal complexes from bipy and phena
E1 (V)

6E, (mV)

Cu(phen),(NO,),

0.34,,,

105

Cu(bipy),(NO,),

0.30
0.22"
0.21"

130
100
130

Compound

Cu(NO,);bipy (1:2)

•JOO m Vis. compound (0.5 mM), electrolyte (0.1 M). PI electrode versus SCE,
adjusted to NHE, DMF unless otherwise indicated
h50% aqueous ethanol
'Insoluble

reduced solubility. A value of about 0.17 V has
been reported under aqueous conditions (Ogura
& Arinobu, 1978; Albert, 1979a; Koppenol,
1987).
The possibility of redox cycling in vivo is
supported by involvement of NADH (Reich et
a/., 1981) (£'' = -0.32 V (Rawn, 1983) ), thiols
(Downey et al., 1980; Gutteridge & Halliwell,
1982), or ascorbate (Chiou, 1984) in DNA scission by phenanthroline chelates of copper. The
autoxidation involving thiols generates oxy
radicals (Downey et a/., 1980; Marshall et a/.,
1981). The different reactivities of various metal
complexes may be reflective of the different
redox potentials (Chiou, 1984). The cupric complex inhibits polymerase activity which may be
related to its ability to cleave DNA and generate
toxic oxy species (Sigman et a/., 1979); the
reaction is blocked by catalase. The Cu·2,9dimethylphenanthroline adduct, £ 1 = 0.88 V
(Patterson & Holm, 1975), does not cleave DNA
(Reich et a/., 1981). This may be due to the
absence of redox cycling resulting from steric
interactions (Sigman, 1986).
The Cu(3,4, 7,8-tetramethylphenanthroline )2
cation exhibits anti-tumor properties (Dwyer et
a/., 1965; Mayhew et a/., 1965). A reduction
value slightly less than 0.34 V is expected as a
result of the alkyl substituents (Albert, 1985;
Ames et a/., 1986a).
Ruthenium(II)
tetramethylphenanthroline
complexes are also effective against tumors
(Dwyer et a/., 1965; Mayhew et al., 1965). The
stability of the cations suggests that their biological effects are due to the complex as a whole

rather than the individual constituents from
dissociation (Dwyer et a/., 1965). The complex
cleaves DNA upon irradiation (Mei & Barton,
1986). Recently, Clarke eta/. (1986) proposed
that Ru(ll) ammine complexes with DNA may
exert their activity by redox cycling in the presence of oxygen and a reducing agent, producing
active oxygen species which cleave the polymer.
The bipy copper species behaved in a manner
analogous to the phen counterparts in DMF.
The £ 1 was 0.30 V with E v!2 = 130m V and
current ratio of0.97 (Table IIJ. One electron was
involved (see above), CF ratio = 0.79. The
difference in E, values (40mV) for the phen
versus the bipy complexes in our work is similar
to a reported value (50 mV) under aqueous
conditions (Albert, 1979a; Koppenol, 1987).
In aqueous ethanol Cu(bipy),(NO,), took up
an electron at 0.22 V. Again, the reaction was
diffusion controlled and quasi-reversible
(6Ev = IOOmV; iv,fi"' = 0.92) (Table II). We
also investigated the complex formed in situ
(E, = 0.20 V). Prior studies have found a value
o(O.I2 V in neutral solution (Albert, 1979a).
In the presence of oxygen and a reducing
agent the complexes from bipy and phen generate superoxide (Graham et a/., 1980). Phen
chelates are generally more potent than corresponding bipy compounds against leukemia
(Shulman et a/., 1977), as in the anti-bacterial
realm (Albert, 1979a), and they also possess
more positive reduction potentials (Table II and
Albert, 1979a). Phenanthroline chelates of
Ru(II) may interfere with biological redox reac- :
lions (Dwyer eta/., 1969).
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Hydroxyurea Hydroxyurea is very active
against LI210 lymphoid leukemia, and is a
metal binder (Harmon et a/., 1970; Berger &
fritz, 1972; Albert, 1979b). Metal chelation may
correlate with biological activity. The molecular
basis for its selectivity is attributed to the sequestering of iron required by the iron-dependent
enzyme ribonucleoside diphosphate reductase
(Albert, 1979b). In line with our general premise, we studied the redox properties of solutions
containing HU and iron(III) ·or copper(II). The
results are summarized in Table Ill.
The Fe(Ill)·HU (1:1) solution gave quasireversible reduction at 0.31 Y in DMF with an
average separation of 180m Y between the cathodic and anodic peaks; this solvent was chosen
because of instability of the complex under
aqueous conditions (Harmon et a/., 1970). The
process was 83% reversible (i Ji" x 100%).
Changing the solvent to ethanofJDMF (75/25)
_resulted in an anodic shift of the first peak to
£ = 0.56 V. The reaction was more reversible
1
With 6£, and i,ji"' of 140 mY and 1.0, respecti:vely; HU did not reduce before the background
-discharge. In the case of iron, the in situ com-

Table III

Fe(lll)·HU (1:1)
Cu(li)·HU (1:2)
Fe( III)· DOC (I :I)
Cu(li)·DDC (1:1)
Fe(lll)·l (2:1)
Fe(lll)·8-quinolinol
FcCI 1

Cu(N0,),-3H,O
HU
DOC

plexes reduced at the same potential as FeCI 1 in
the solvents used. However, the solutions that
contained both FeCI 1 and HU were dark green
as reported for other non-aqueous systems
(Harmon et a/., 1970), whereas the solutions
with iron alone were yellow.
Complexation with copper (I :2) (Harmon et
a/., 1970) in aqueous ethanol produced an irreversible (£, 12 = 140 mY) reaction at 0.30 Y.
Chelation brings about an increase of 0.1 Y in
the reduction potential of the metal (Table III).
HU gave no reduction before -0.2 Y. A previous study reported an£\ value of -0.5 Y at
pH 6.8 (Wold eta/., 1980).
The involvement of HU in radical reactions is
reasonable since the cytotoxic effects are lessened by radical scavengers, e.g. SOD, a-tocopherol, and ascorbic acid (Przybyszewski &
Malec, 1982; Szczepannska et a/., 1985). Preliminary experiments indicate that the teratogenic activity ofHU may result from the generation of oxy radicals (De Sesso, 1979). H U
exhibits electron carrier properties by acting as a
conduit between NADH and oxygen with
reduction of nitroblue tetrazolium. SOD in-

Voltammctry of metal complexes from HU, DDC, and 1"

Solution

E1 (V)

6E, (mV)

0.31
0.56"
0.30'
- 0.20"
-0.49
0.28
0.27'
0.31
0.56"
0.20'
0.04'
NRb·"
> -0.2'
NR•

180
140
140
70
100
190
310

100m V,/s, metal concentration (0.5 mM) unless otherwise indicated, TEAP (0.1 M),
platinum flag versus SCE, adjusted to NHE, DMF unless otherwise indicated
Ethanol/DMF (75/25), 0.05 mM TEAP, single determination
'50% aqueous ethanol, irreversible, EPP 2 value
dJrreversible; Erp.? value
<NR: no reduction
a

0
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hibited the reaction. Other relevant observations
include methemoglobin formation, sensitivity to
oxidant stress, and blockage of DNA synthesis
similar to that induced by X-rays (Przybyszewski & Malec, 1987).
Diethyldithiocarhamate Diethyldithiocarbamate
(DOC) exhibits anti-cancer properties (Spath &
Tempel, 1987). Since dithiocarbamates are
known to form metal chelates (Manoussakis &
Bolos, 1985; Amatore eta/., 1988; Trombetta et
a/., 1988), one can plausibly consider these derivatives as the active agents. The redox characteristics of the iron(Ill)·DDC (1:1) solution are
given in Table III. This ratio was chosen because
saturation of the metal with ligand nullifies the
toxic effects of the chelate (Spath & Tempel,
1987); presumably, open positions are needed
for site binding. The ferric solution gave reduction at -0.20V (£, 12 = 70mV), coupled to a
small wave at 0.16 V. The large wave separation
and reduced height of the oxidation portion may
be due to dissociation of the complex after
reduction; prior workers have observed such
effects (Toropova et a/., 1978). Complexation
with iron(III) resulted in a decrease of approximately 500 m V in the reduction potential of the
metal. In another control experiment, the ligand
gave no reaction before the background. The
cupric complex reduced at - 0.49 V in a process
that was 91% reversible with 6£, of lOOmV.
Related electroanalytical studies of metal chelates (1:2) have been reported (Hendrickson et
a/., 1976; Toropova et a/., 1978); an alcoholic
benzene solution of the copper coordination
compound reduced at -0.30 V (Cordova eta/.,
1977).
Data suggest that cytotoxicity is peroxidative
with involvement of copper (Trombetta et a/.,
1988). Inhibition by glutathione was observed.
Strong copper chelators reduced the toxicity.
The anti-tumor activity of DDC is increased by
hyperbaric oxygen (Petrovskii eta/., 1982). The
Cu· DOC compound is highly toxic to algae,
apparently due to participation of Fenton
chemistry with formation of hydroxyl radicals
(Florence et a/., 1983). Involvement of superoxide has been suggested for the initial toxicity
of this complex (Spath & Tempel, 1987).
Alternatively, DOC has been proposed to inhibit SOD (Lin eta/., 1979; Forman eta/., 1980;

"~"'"

" oi.,

""'l· ""'

i~

,;,, '""ro'i"'

unchecked, which may explain the potentiation
of bleomycin toxicity (Lin et a/., 1980). It also
inhibits lipid peroxidation (Freund! eta/., 198la
and b; Younes eta/., 1984), but has no dismutating activity (Lengfelder, 1979).
The dimethyl analog is a potent fungicide, but
only in complex (copper) form (Albert, 1979a).
Concentration quenching is evident. Oxidative
destruction of lipoic acid is believed to be the
molecular mode of action.
8-Hydroxyquino/ine derivatives The bt:< derivative 1 of 8-hydroxyquinoline which readily chelates metals was found to have high activity
against leukemia P388 (Yamato et a/., 1987).
The action is attributed to complexation with
the iron of ribonucleotide reductase which catalyses DNA biosynthetic pathways. Recently, we
proposed that several agents, (P-lactams,
(Kovacic et a/., 1987; Kovacic et a/., 1988c),
methotrexate and u-difluoromethylornithine
(Kovacic et a/., 1988f)) which are thought to
exert their activity solely by enzyme inactivation, may also be involved in electron transport.
In this context, we carried out electrochemical
studies on the Fe(Ill)-1 complex (2: 1); some
isomer may be present (see the experimental
section). Reduction occurred quasi-reversibly at
0.28 V with i,./i of0.89 and 6£, of 190 mV in
DMF (Table nl'), similar to Fe(Ill)·8-quinolinol
(1:1): £ 1 = 0.27V, 6£, = 310mV, i,)ir< =
0.87. The corresponding aqueous system was
not examined due to reduced solubility of 1.

AH3

CHU)

H O y OH

,PI'<:
;:,._

Q

1
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The physiological (anti-bacterial) effects of 8bydroxyquinoline likely arise from the generation of metal compounds (Ames et a/., 1986b;
Shterev & Kaneti, 1986). Metal coordination
01ay be involved in the anti-cancer properties of
streptonigrin in the 8-quinolinol form (Boger et
a/., 1987). Various 8-hydroxyquinoline complexes of Fe(III) accelerate lipid peroxidation
(Hayakawa et a/., 1982) which is prevented by
antioxidants (Ohtsuka et al., 1982). Oxy radical
generation has been shown for l;>oth endogenous

and exogenous compounds of iron and copper
(Ames eta/., 1986b).
The tropolone analogs of 1 also exhibit antitumor activity, possibly due to metal chelation
(Yamato eta/., 1987).
Other considerations
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Some of the complexing agents treated in this
work show activities in other areas, e.g. bipy or
phen, anthelmintic (Albert, 1979a), antibacterial
(Shulman et a/., 1972), DDC, antifungal, and
antimycobacterial (Albert, 1979a) which may be
related to ET reactions (Ames et a/., 1986b;
Kovacic et a/., 1988d).
Application of the general theme has also
been made to ~-lactam antibiotics (Kovacic et
a/., 1987b; Kovacic et a/., 1988c), cocaine
(Kovacic et a/., 1988e), antiprotozoan agents
(Ames eta/., 1987b), anthclmintics (Kovacic et
a/., 1988d), and amebicides (Ames eta/., 1987a).
References to other areas investigated (benzodiazepines,
1-methyl-4-phenyl-1 ,2,3,6-tetrahydropyridine, mesoionic compounds, carcinogens, phencyclidine, nicotine, spermine, and
antibacterial agents) are given elsewhere (Ames
eta/., 1986b; Crawford eta/., 1986; Ames et a/.,
1987a and b). Redox cycling involving electron
transfer is increasingly implicated in the
mechanism of action of various drugs, and has
been reviewed (Halliwell & Gutteridge, 1985;
Kappus, 1986).
In summary, various steps seem to be
involved in the physiological activity. Site binding occurs, frequently involving DNA (Basile &
Barton, 1987). As a result, there could be interference with DNA replication or other essential
processes.
Our electrochemical
evidence
suggests the participation of ET. Redox cycling
can generate toxic oxy radicals or interfere with
normal electron transport. DNA binding might
favor reversibility and an increased reduction
potential (Ames et a/., 1986c; Crawford et a/.,
I986; Carter & Bard, 1987).

In response to the question concerning the
actual form of the active metal species, there are
several possibilities. Generally, binding to DNA
appears to take place. In one case, the drug
itself, e.g. Cu·phen, (Sigman, 1986), attaches to
the surface and functions as such. This category
encompasses the most stable complexes. The
other class includes the chelates that are more
prone to dissociation, namely, bis(acetato)his
(imidazole)Cu(II), ruthenium ammine complexes (Clarke eta/., 1986), and cis-DDP (Kovacic eta/., 1986). Fixation to the active site entails
coordination to a ligand in DNA. In the
exchange process, ligands from amino or thiol
groups of protein could also become involved.
Presumably, binding to DNA is followed by
induction of ET at a sensitive locale.
A number of correlations between reduction
potential and activity have been noted for bipy,
phen, DDC and 1 (see above). Prior work
(Kovacic eta/., 1986; Crawford eta/., 1987) has
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